Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bristol Myers Squibb Stock Rises
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.
Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval
Key Takeaways Bristol Myers Squibb's drug to treat schizophrenia was approved for use by the Food and Drug Administration.The pharmaceutical firm called Cobenfy the first new treatment for the illness in decades.
Bristol-Myers Squibb: Unlocking Value With KarXT FDA Approval And Oncology Pipeline Progress
Bristol-Myers Squibb received FDA's approval for Cobenfy, which is poised to be a game changer in the treatment of Schizophrenia. See why BMY stock is a Buy.
Law
1d
Bristol-Myers Squibb Wins Dismissal of $6.4 Billion Lawsuit Alleging Intentional Delay of Cancer Drug
A New York federal judge has dismissed a $6.4 billion lawsuit against
Bristol
-
Myers
Squibb
Co., agreeing with counsel ...
1d
Hold Rating on Bristol-Myers Squibb Amid Market Challenges and Strategic Execution Risks
Leerink Partners analyst David Risinger has maintained their neutral stance on BMY stock, giving a Hold rating on September 26. David Risinger ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Court filing made public
Helene's wake
Walz, Vance VP debate
Teacher wins pronouns case
Repairman's claims rejected
NASCAR sued by Jordan
Factory probed after Helene
WW2-era bomb explodes
Doctor pleads guilty
ABC News layoffs
Strike leads to panic-buying
Man sentenced for cloning
Drop box ban lawsuit
Bank of America outage
CA food chemicals ban
Historic ship reef plan
Blasts near Israeli Embassy
CO2 found on Pluto's moon
Israel sends more troops
Labor board targets Apple
AR marijuana expansion suit
Valuation reaches $157B
GA disaster declaration
1K troops to aid NC
Nintendo opens museum
Port strike hits day 2
AG appeals abortion ruling
May face additional charges
AZ voter registration glitch
November trial set
Partners with UK banks
Murdaugh's appeal rejected
Feedback